Real-World safety check for agitation inhaler
Knowledge-focused
Terminated
This study observes the safety of ADASUVE (loxapine inhalation) in up to 10,000 adults with agitation from schizophrenia or bipolar I disorder. It tracks side effects in real-world emergency or inpatient settings. The study is observational, meaning no new treatment is given—just…
Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC